Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-31 @ 11:04 PM
Study NCT ID:
NCT05468294
Status:
UNKNOWN
Last Update Posted:
2022-07-21
First Post:
2022-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Sponsor:
Philogen S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-23
First Submit QC Date:
None
Study First Post Date:
2022-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-19
Last Update Post Date:
2022-07-21
Last Update Post Date Type:
ACTUAL